N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-methoxyimidazo[1,2-b]pyridazin-3-yl)benzamide;fluoromethane
C20H21F3N4O4 — CID 155727755
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-methoxyimidazo[1,2-b]pyridazin-3-yl)benzamide;fluoromethane
N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-methoxyimidazo[1,2-b]pyridazin-3-yl)benzamide;fluoromethane (PubChem CID 155727755) has the molecular formula C20H21F3N4O4 and a molecular weight of 438.41 g/mol. Its IUPAC name is N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-methoxyimidazo[1,2-b]pyridazin-3-yl)benzamide;fluoromethane.
Molecular Properties
| Compound Name | N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-methoxyimidazo[1,2-b]pyridazin-3-yl)benzamide;fluoromethane |
|---|---|
| PubChem CID | 155727755 |
| Molecular Formula | C20H21F3N4O4 |
| Molecular Weight | 438.41 g/mol |
| Exact Mass | 438.15 |
| IUPAC Name | N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-methoxyimidazo[1,2-b]pyridazin-3-yl)benzamide;fluoromethane |
| SMILES | CF.COc1cnn2c(-c3cc(OC)c(C(=O)NC4CC4)c(OC(F)F)c3)cnc2c1 |
| InChI | InChI=1S/C19H18F2N4O4.CH3F/c1-27-12-7-16-22-9-13(25(16)23-8-12)10-5-14(28-2)17(15(6-10)29-19(20)21)18(26)24-11-3-4-11;1-2/h5-9,11,19H,3-4H2,1-2H3,(H,24,26);1H3 |
| InChIKey | NNWZMXAGKVIXEW-UHFFFAOYSA-N |
| XLogP | 3.49 |
| TPSA | 86.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.41 |
| LogP ≤ 5 | 3.49 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155727755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.